{"schema":"hottub-news/story/v1","story":"st_vh655tugrcdjojn4w47a","title":"Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/wave-life-sciences-announces-gsks-selection-of-sirna-program-to-vh655tugrc","count":1,"items":[{"id":"n_vh655tugrcdjojn4w47a","seq":890180,"kind":"press_release","title":"Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development","url":"https://www.globenewswire.com/news-release/2026/09/30/3371781/0/en/wave-life-sciences-announces-gsk-s-selection-of-sirna-program-to-transition-to-gsk-for-further-development.html","summary":"Candidate selected by GSK utilizes Wave’s best-in-class SpiNA design siRNA and triggers a milestone payment to Wave; three additional collaboration programs advancing","published":"2026-09-30T11:30:00Z","seen":"2026-09-30T11:32:38Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:wve","sg9999014716"],"entities":[{"id":"Q91396922","name":"Wave Life Sciences","type":"org"},{"id":"Q212322","name":"GSK","type":"org"}],"mentions":2,"story":"st_vh655tugrcdjojn4w47a","category":"science-technology","category_p":0.6800000071525574,"sentiment":"positive","tone":0.5699999928474426,"political":0.019999999552965164}]}